Vabysmo - direct healthcare professional communication (DHPC)

Faricimab

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC) : Vabysmo (faricimab): tear in primary packaging of transfer filter needle (TFN) co-packaged with vial

Key facts

• Medicine name:
  Vabysmo
• Active substance:
  Faricimab
• Therapeutic area (MeSH):
  • Wet Macular Degeneration
  • Macular Edema
  • Diabetes Complications
• DHPC type:
  Quality defect
• Human ATC codes:
  S01L
• Dissemination date:
  25/07/2024